Riskpilot← Back to searchSign inGet full accessCLINIGMA ApS
APSActiveCVR 39350580Rosenborggade 1A, 6.All other professional, scientific and technical activities n.e.c. · NACE 7499Est. 20187 employeeswww.clinigma.com
Revenue 2024
DKK 3,2M
-49% vs 2023
EBITDA margin
48.3%
-50% vs 2023
Equity ratio
-18.4%
Financial strength
Net profit 2024
DKK -134K
-106% vs 2023
| Revenue | DKK 3,2M | -49% |
| EBITDA | DKK 1,5M | -50% |
| Net profit | DKK -134K | -106% |
| Total assets | DKK 11,6M | +123% |
| Equity | DKK -2,1M | -73% |
| Employees | 7 | — |
Legal name
CLINIGMA ApS
CVR number
39350580
Legal form
Anpartsselskab
NACE code
7499 · All other professional, scientific and technical activities n.e.c.
Founded
15. februar 2018
Share capital
DKK 61.111
Employees
7 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den adm. Direktør i forening med bestyrelsesformanden eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at drive virksomhed med at interviewe og foretage spørgeskemaundersøgelser bland brugere af medicin og medicinsk udstyr i forbindelse med kliniske studier og/eller i hverdagen og hermed forbundet virksomhed
Address
Rosenborggade 1A, 6.
Phone
+4531901780
Email
ch@clinigma.com
Website
www.clinigma.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 62 | 1.096 | 5.330 | -60 | 2.913 | 6.234 | 3.188 |
| Staff expenses | -20 | -332 | -1.730 | -2.561 | -2.938 | -3.183 | -4.167 |
| EBITDA | 42 | 17 | 3.599 | -2.621 | -25 | 3.051 | 1.539 |
| Depreciation & amort. | -31 | -23 | -0 | -6.919 | -0 | -261 | 1.259 |
| EBIT | 11 | -6 | 3.599 | -9.540 | -25 | 2.790 | 280 |
| Net financials | -0 | -7 | -14 | -121 | -57 | -444 | -414 |
| Profit before tax | 11 | 1 | 3.586 | -9.661 | -82 | 2.346 | -134 |
| Tax | -0 | -0 | 816 | -10 | -178 | -0 | -0 |
| Net profit | 11 | 1 | 2.770 | -9.651 | 96 | 2.346 | -134 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | 332 | 732 | 7.284 | 512 | 4.013 | 5.191 | 11.561 |
| Equity | 61 | 562 | 2.937 | -6.714 | -3.580 | -1.234 | -2.131 |
| Long-term debt | 0 | 0 | 453 | 1.407 | 3.112 | 957 | 5.597 |
| Short-term debt | 271 | 170 | 3.222 | 5.147 | 4.481 | 5.468 | 8.094 |
| Total debt | 271 | 170 | 3.675 | 6.554 | 7.593 | 6.425 | 13.692 |
EBITDA margin
48.3%
This company
15.8%
Market median
+206% vs market
20182024
Equity ratio
-18.4%
This company
38.2%
Market median
-148% vs market
20182024
Return on equity
-13393900.0%
This company
18.4%
Market median
-72793035% vs market
20182024
Net profit margin
-4.2%
This company
8.1%
Market median
-152% vs market
20182024
Asset turnover
0.28×
This company
1.12×
Market median
-75% vs market
20182024
Debt / equity
6.43×
This company
0.62×
Market median
-937% vs market
20182024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-02-15 – 2018-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JH Founder | Founder | 2018 | — | — |
CB Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — | |
| Chairman | 2022 | — | — | |
| Chairman | 2025 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Kongsø Gruppen ApS | Company | 90.0% | 66.7% | 2026 |
CH Technologies Holding ApS | Company | 10.0% | 10.0% | 2026 |
3XHV ApS | Company | 5.0% | 5.0% | 2022 |
BACVib ApS | Company | 5.0% | 5.0% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Kongsø Gruppen ApS
CLINIGMA ApS Board members of CLINIGMA ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jens Harald Kongsø | Founder | 0 companies |
| Christian Bredmose Holm | Chief Executive Officer | 0 companies |
| Morten Bøgenskjold | Board of Directors | 0 companies |
| Klaus Ringgård Bak | Chairman | 0 companies |
| Rune Tarnø | Chairman | 0 companies |